Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9004214 | 0.88 | CA2 (0.30) | — | |
| SCHEMBL13246061 | 0.83 | CYP1A2 (0.31) | CYP3A4 | |
| SCHEMBL7029199 | 0.82 | — | — | |
| SCHEMBL6906715 | 0.81 | CA1 (0.46) | LMNATP53CYP3A4HPGDALOX15 | |
| SCHEMBL29851517 | 0.81 | CA1 (0.46) | LMNATP53CYP3A4HPGDALOX15 | |
| SCHEMBL13290054 | 0.81 | RARG (0.31) | — | |
| SCHEMBL22996234 | 0.81 | — | — | |
| SCHEMBL10305207 | 0.80 | GABRA1 (0.31) | — | |
| SCHEMBL86121 | 0.80 | HTR1D (0.37) | — | |
| SCHEMBL31194410 | 0.80 | HTR1D (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0885911-B1 | Two-component catalyst for ring-opening metathesis polymerization | CIBA SC HOLDING AG (CH) | 2003-06-18 | — | — | EP | claimed |
| US-5998326-A | Two-component catalyst for ROMP | CIBA SPECIALTY CHEMICALS CORP. (US) | 1999-12-07 | — | — | US | claimed |
| EP-0885911-A1 | Two-component catalyst for ring-opening metathesis polymerization | Ciba SC Holding AG (CH) | 1998-12-23 | — | — | EP | claimed |
| WO-2019053187-A1 | ADDITIVE MIXTURE | BASF SE (DE) | 2019-03-21 | — | — | WO | disclosed |
| WO-2019007935-A1 | A POLYETHYLENE PIPE | BASF SE (DE) | 2019-01-10 | — | — | WO | disclosed |
| US-9039946-B2 | Reversibly thermochromic compositions | BASF SE (DE) | 2015-05-26 | — | — | US | disclosed |
| EP-1888686-B1 | SCRATCH RESISTANT POLYOLEFINS | BASF SE (DE) | 2013-01-23 | — | — | EP | disclosed |
| US-20100036083-A1 | Process For The Preparation Of Polyamides In The Presence of a Phosphonate | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-02-11 | — | — | US | disclosed |
| US-20090302284-A1 | Reversibly Thermochromic Compositions | CIBA CORPORATION | 2009-12-10 | — | — | US | disclosed |
| EP-1008580-B2 | Process for preparing aldehydes and alcohols | MITSUBISHI CHEM CORP (JP) | 2008-10-29 | — | — | EP | disclosed |
| EP-1704026-B1 | METHOD OF TREATING RAZOR BLADE CUTTING EDGES | GILLETTE CO (US) | 2008-05-21 | — | — | EP | disclosed |
| US-20070055047-A1 | Molecular weight increase and modification of polycondensates | CIBA SPECIALTY CHEMICALS CORP. | 2007-03-08 | — | — | US | disclosed |
| EP-0885911-B1 | Two-component catalyst for ring-opening metathesis polymerization | CIBA SC HOLDING AG (CH) | 2003-06-18 | — | — | EP | disclosed |
| US-6204347-B1 | CONSIST OF A MIXTURE OF STRAINED CYCLOOLEFIN AND A RUTHENIUM COMPOUND, AND A MIXTURE OF STRAINED CYCLOOLEFIN AND A TERTIARY PHOSPHINE CONTAINING ATLEAST ONE SECONDARY ALKYL REDICAL OR CYCLOALKYL REDICAL TO PHOSPHORUS ATOM | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-03-20 | — | — | US | disclosed |
| US-5998326-A | Two-component catalyst for ROMP | CIBA SPECIALTY CHEMICALS CORP. (US) | 1999-12-07 | — | — | US | disclosed |
| EP-0885911-A1 | Two-component catalyst for ring-opening metathesis polymerization | Ciba SC Holding AG (CH) | 1998-12-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090302284-A1 | Reversibly Thermochromic Compositions | DHCR7, NES, DUT | LMNA 1554/4885TP53 505/4885CYP3A4 998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.